Agreements with AstraZeneca and the University of Nebraska Medical Center showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis
RiboShield RNase Inhibitor complements PCR Biosystems’s range of products to support COVID-19 research and testing
The agreement is part of preparations for GMP production of material for the first clinical study of CG01
Leinco Technologies has launched the COVID-19 ImmunoRank Neutralization ELISA Test Kit
Watch this on-demand webinar to discover the critical factors when choosing an assay for coronavirus testing
Join us on Monday, September 21, to learn about assay development for high-throughput screening
New research published in Nature Immunology show strong T cell responses in patients recovered from COVID-19
CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO
New test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus and Epstein-Barr virus
Test to be integrated in over 5,000 DiaSorin analyzers, allowing physicians to differentiate between bacterial and viral infections
Sanofi and GSK are scaling up the manufacturing of the antigen and adjuvant with the target of producing up to one billion doses in 2021
Following successful evaluation by The Liverpool School of Tropical Medicine, the ELISA test will now be made available for COVID-19 researchers
Read this application note to discover how T cell activation assays can help accelerate COVID-19 vaccine development
Data shows 100% concordance with results from Dartmouth-Hitchcock’s lab-based polymerase chain reaction (PCR) test method
Rapid increase in production of VTM and saline will help boost virus testing
A new prognostic tool developed by an international team led by CTI-Bath paves the way for personalized medicine for cancer patients
Watch this on-demand webinar to learn about the latest approaches in single nucleus transcriptomics and ATAC-Seq
The new AI technology will learn from past CT scans of COVID-19 pneumonia patients, reducing the burden on doctors making diagnoses
Ready-to-use kit enables rapid adeno-associated virus (AAV) titer determinations during the manufacture of AAV vectors
Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions
Meet the researchers making waves in science and learn about the technologies innovating their research
